This is out Library. Please click on the article title to view the details.
submitted by: admin on 06/24/2016
Low dose naltrexone (LDN) has been implicated to help with cancer, HIV/AIDS, autoimmune diseases, and much more. Now it has been shown to have a potent antitumor effect on human ovarian cancer in both tissue culture and in animal xenografts. Naltrexone (NTX) is a general opioid receptor antagonist that results in compensatory elevation in endogenous opioids and...